Literature DB >> 17351709

The ACVR1 617G>A mutation is also recurrent in three Japanese patients with fibrodysplasia ossificans progressiva.

Masahiro Nakajima1, Nobuhiko Haga2,3,4, Kazuharu Takikawa2,3, Noriyo Manabe3, Gen Nishimura5, Shiro Ikegawa6.   

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder of skeletal malformations and presents progressive extra-skeletal ossification. The 617G>A (R206H) mutation in the activin receptor type IA (ACVR1) gene has been identified in all examined individuals with FOP of various ethnic groups, including Caucasian and Chinese descents. Here, we examined three Japanese patients with FOP for ACVR1 mutations. We identified the 617G>A mutation in all three patients. Our results suggest that the mutation in the ACVR1 gene is common and recurrent in the global population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17351709     DOI: 10.1007/s10038-007-0128-3

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  14 in total

1.  Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification.

Authors:  Michael N Wosczyna; Arpita A Biswas; Catherine A Cogswell; David J Goldhamer
Journal:  J Bone Miner Res       Date:  2012-05       Impact factor: 6.741

2.  A novel ACVR1 mutation in the glycine/serine-rich domain found in the most benign case of a fibrodysplasia ossificans progressiva variant reported to date.

Authors:  Celia L Gregson; Peter Hollingworth; Martin Williams; Kirsten A Petrie; Alex N Bullock; Matthew A Brown; Jon H Tobias; James T Triffitt
Journal:  Bone       Date:  2010-10-29       Impact factor: 4.398

Review 3.  Fibrodysplasia ossificans progressiva: clinical course, genetic mutations and genotype-phenotype correlation.

Authors:  Irina Hüning; Gabriele Gillessen-Kaesbach
Journal:  Mol Syndromol       Date:  2014-08-07

4.  Clinical and molecular characterisation of two siblings with fibrodysplasia ossificans progressiva, from the Colombian Pacific coast (South America).

Authors:  Harry Pachajoa; Andres Felipe Ramirez Botero
Journal:  BMJ Case Rep       Date:  2015-06-08

5.  Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva.

Authors:  Toru Fukuda; Masakazu Kohda; Kazuhiro Kanomata; Junya Nojima; Atsushi Nakamura; Jyunji Kamizono; Yasuo Noguchi; Kiyofumi Iwakiri; Takeo Kondo; Junichi Kurose; Ken-ichi Endo; Takeshi Awakura; Junichi Fukushi; Yasuharu Nakashima; Tomohiro Chiyonobu; Akira Kawara; Yoshihiro Nishida; Ikuo Wada; Masumi Akita; Tetsuo Komori; Konosuke Nakayama; Akira Nanba; Yuichi Maruki; Tetsuya Yoda; Hiroshi Tomoda; Paul B Yu; Eileen M Shore; Frederick S Kaplan; Kohei Miyazono; Masaru Matsuoka; Kenji Ikebuchi; Akira Ohtake; Hiromi Oda; Eijiro Jimi; Ichiro Owan; Yasushi Okazaki; Takenobu Katagiri
Journal:  J Biol Chem       Date:  2008-08-06       Impact factor: 5.157

6.  Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressiva.

Authors:  Ilham Ratbi; Renata Bocciardi; Asmaa Regragui; Roberto Ravazzolo; Abdelaziz Sefiani
Journal:  Clin Rheumatol       Date:  2009-10-01       Impact factor: 2.980

7.  Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements.

Authors:  Renata Bocciardi; Domenico Bordo; Marco Di Duca; Maja Di Rocco; Roberto Ravazzolo
Journal:  Eur J Hum Genet       Date:  2008-10-01       Impact factor: 4.246

8.  Novel mutations in ACVR1 result in atypical features in two fibrodysplasia ossificans progressiva patients.

Authors:  Kirsten A Petrie; Wen Hwa Lee; Alex N Bullock; Jenny J Pointon; Roger Smith; R Graham G Russell; Matthew A Brown; B Paul Wordsworth; James T Triffitt
Journal:  PLoS One       Date:  2009-03-30       Impact factor: 3.240

9.  ACVR1 gene mutation in sporadic Korean patients with fibrodysplasia ossificans progressiva.

Authors:  Dong Yeon Lee; Tae-Joon Cho; Hye Ran Lee; Moon Seok Park; Won Joon Yoo; Chin Youb Chung; In Ho Choi
Journal:  J Korean Med Sci       Date:  2009-06-12       Impact factor: 2.153

10.  Mutation Detection in Activin A Receptor, Type I (ACVR1) Gene in Fibrodysplasia Ossificans Progressiva in An Iranian Family.

Authors:  Ziba Morovvati; Saeid Morovvati; Gholamhossein Alishiri; Seyed Hossein Moosavi; Reza Ranjbar; Yaser Bolouki Moghaddam
Journal:  Cell J       Date:  2014-02-03       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.